Skip to content

YOga for Patients With Chronic BACK Pain and Poor PROgnosis

Effectiveness of YOga in Patients With Chronic Low BACK Pain and Poor PROgnosis (YOBACK-PRO Trial): a Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05953155
Acronym
YOBACK-PRO
Enrollment
110
Registered
2023-07-19
Start date
2023-07-27
Completion date
2026-03-26
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Back Pain Lower Back Chronic, Chronic Low-back Pain, Low Back Pain

Keywords

low back pain, chronic low back pain, yoga, poor prognosis

Brief summary

The goal of this clinical trial is to investigate the effectiveness of yoga for patients with chronic low back pain and high risk of poor prognosis. The main question it aims to answer is: \- In patients with back pain and high risk of poor prognosis, what is the effectiveness of yoga plus education on reducing pain and disability compared to a control group receiving education alone? A total of 110 patients with chronic low back pain and classified as high risk of poor prognosis according to the Orebro Musculoskeletal Pain Screening Questionnaire (i.e. score ≥ 50 points out of 100) will be recruited for this study. Participants will be randomized into two groups: yoga and control. The yoga group will receive a 3-month course of yoga program consisting of two sessions per week and 3 educational classes. The control group will receive 3 educational classes over a 12-week period. Outcome measures will be assessed at baseline, at post-intervention (i.e. 3-months post randomization) and at 6-month follow up (i.e. 6-months post randomization).

Interventions

OTHERControl

Each educational class will last for 1 hour and consists of evidence-based information about low back pain, including, for example, self-management strategies, pain education, reassurance and common misconceptions about back pain.

OTHERYoga

Participants in the intervention group will receive, in addition to the educational classes, a course of yoga program led by certified yoga instructors. The program consists of a 60-min group session with up to 10 participants, delivered twice a week for 12 weeks.

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* report chronic nonspecific LBP, defined as pain and discomfort localized below the costal margin and above the inferior gluteal folds, with or without leg pain and of at least 3 months' duration. * score ≥ 50 points (out of 100) in the Orebro Musculoskeletal Pain Questionnaire. * have an average back pain intensity of 3 points or more on a 0-10 numerical pain rating scale.

Exclusion criteria

* serious spine pathology (e.g. tumors, fractures, and inflammatory diseases). * nerve root compromise (i.e. at least 2 of the following signs: weakness, reflex change, or sensation loss associated with the same spinal nerve). * previos spinal surgery. * pregnancy or having given birth within the previous 3 months. * any medical condition that prevented being physically active (e.g., serious cardiovascular, kidney or neurological diseases). * any other musculoskeletal condition that may affect activity and movement participation in a Yoga program during the last year. * not currently receiving other physical activity-based intervention (e.g., Pilates, physical therapy, aquatic exercise). * inadequate Portuguese literacy for the study's questionnaires and instructions.

Design outcomes

Primary

MeasureTime frameDescription
DisabilityPost-intervention (i.e. 3 months after randomisation)Roland Morris Disability Questionnaire (RMDQ) (0-24 scale)

Secondary

MeasureTime frameDescription
Disability6 months after randomisationRoland Morris Disability Questionnaire (RMDQ) (0-24 scale)
Pain intensityPost-intervention (i.e. 3 months after randomisation) and at 6-month follow-upNumerical Rating Scale for Pain assessment (NRS) (0-10 scale)
Quality of lifePost-intervention (i.e. 3 months after randomisation) and at 6-month follow-upEuroQol Visual Analogue Scale (EQ-VAS) (0-100 scale)
Depressive symptomsPost-intervention (i.e. 3 months after randomisation) and at 6-month follow-upCenter for Epidemiological Studies - Depression (CES-D) (0-60 scale)
Pain self-efficacyPost-intervention (i.e. 3 months after randomisation) and at 6-month follow-upPain Self-Efficacy Questionnaire (PSEQ) (0-60)

Countries

Brazil

Contacts

PRINCIPAL_INVESTIGATORRafael Z Pinto, PhD

Federal University of Minas Gerais

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026